Scout | PAR-23-268: Development of Novel Extracellular Vesicle-Based Therapeutic Platforms for Regenerative Medicine

This opportunity is no longer accepting applications.

grant PAR-23-268

Development of Novel Extracellular Vesicle-Based Therapeutic Platforms for Regenerative Medicine

Summary

This grant is designed to fund projects that develop new technologies using extracellular vesicles for regenerative medicine. It targets advancements in creating, producing, and utilizing these vesicles as therapeutic solutions.

This funding opportunity aims to support the development of novel extracellular vesicle-based therapeutic platforms for regenerative medicine. The focus is on platform-oriented technology development related to the production, manufacturing, and use of extracellular vesicles as therapeutics.

Funding Source

Agency: National Institutes of Health

Sub-agency: National Center for Advancing Translational Sciences

Program: STTR

Phase: Phase II

Phase: Phase I

Awards & funding

Award Ceiling: $295,924

Award Amount: $295,924

Eligibility

Joint ventures that qualify as SBCs — legal JV form permitted if the JV meets all SBC requirements and has less than 50% participation by foreign business entities

Tribal/ANC/NHO‑owned small business concerns — SBCs more than 50% owned by an Indian tribe, Alaska Native Corporation (ANC), or Native Hawaiian Organization (NHO), or a wholly owned business entity of such tribe/ANC/NHO

Only U.S. small business concerns (SBCs) may apply as the applicant/awardee for this STTR opportunity.

Core SBC eligibility requirements (must be met at time of award for Phase I and II):

Organized for profit; place of business located in the United States; operates primarily…

Dates

Opportunity Released: April 18, 2023

Open for Submission: April 18, 2023

Submission Deadline: June 6, 2025

Application Window Closes: June 6, 2025

Supporting links

National Institutes of Health

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers